Results 91 to 100 of about 22,113 (119)

[Progress on the development of the SARS-CoV-2 vaccine and antibody drugs]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2022
Xu S, Tang D.
europepmc   +1 more source

[Clinical characteristics and risk factors for disease progression in patients with anti-gp210 antibody-positive primary biliary cholangitis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Ran Y   +10 more
europepmc   +1 more source

[Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2022
Zhang L   +6 more
europepmc   +1 more source

免疫印迹技术检测多种风湿病多肽抗体的临床价值

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1993
本文对20例系统性红斑狼疮(SLE)、7例干燥综合征(SS)、9例类风湿关节炎(RA)、15例结缔组织病(CTD)及10名正常人用免疫印迹方法(IBT)进行了多肽抗体的检测,结果表明:抗27.776 X10~3IU、13.392 X10~3IU的抗体是SLR特征性抗体,而抗44.64 X10~3IU、46.624 X10~3IU/47.616 X10~3IU的抗体与SS密切相关,同时还提出IBT检测多肽抗体较对流免疫电泳(CIE)敏感,且能测到一些少见的抗体。
doaj  

[Clinical significance of antiphospholipid antibodies in Behcet disease with thrombosis]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Li Y, Wang H, Luo L, Li Y, Li C.
europepmc   +1 more source

[Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2022
Zhang LQ   +8 more
europepmc   +1 more source

[Chinese expert consensus on quality control, result analysis, and reporting of anti-HLA antibody testing in allogeneic hematopoietic stem cell transplantation (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Experimental Diagnostics Group   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy